Financial News
Latest News about MRK
Recent news which mentions MRK
Pfizer to seek authorization of COVID-19 pill ‘as soon as possible’
November 05, 2021
From MarketWatch
Pfizer’s positive antiviral news raises hopes for a new easy-to-take treatment for COVID-19, and cases start to rise again in California
November 05, 2021
From MarketWatch
Todos Medical Says It Wants to Outfox COVID-19 & Cancer Along With Rivals Pfizer & Merck With New Theranostic Approach
November 05, 2021
From Benzinga
Why Pfizer Gained $32 Billion in Market Capitalization Today
November 05, 2021
From Motley Fool
A Deep Dive Into COVID Oral Treatments — What Does the Atea Failure Mean for Oral Antivirals?
November 05, 2021
From Benzinga
2 Buffett Stocks That Look Like Great Buys in November
November 05, 2021
From Motley Fool
Pfizer Touts Encouraging Data For Its COVID-19 Oral Antiviral, With 89% Reduction In Hospitalization, Death
November 05, 2021
From Benzinga
Is It Too Late to Buy Pfizer Stock?
November 05, 2021
From Motley Fool
3 COVID Pill Stocks That Might Be Game-Changers
November 05, 2021
From Motley Fool
The Novavax Rebound Is Just Warming Up
November 05, 2021
From InvestorPlace
Merck Receives Another Boost for Its Top-Selling Drug
November 04, 2021
From Motley Fool
Why AbCellera Biologics Stock Sank 21.6% in October
November 04, 2021
From Motley Fool
WHO warns Europe could see 500,000 more COVID-19 deaths by February amid uneven vaccine take-up, and U.S. starts to give kids their shots
November 04, 2021
From MarketWatch
CNBC's Final Trades: Seagen, Dollar Tree And This Pharma Major
November 04, 2021
From Benzinga
The Daily Biotech Pulse: Merck's Oral COVID-19 Pill Authorized In UK, Novartis Cashes Out Of Roche, Chimerix Plunges On Data, Evotec IPO
November 04, 2021
From Benzinga
Britain Approves First Oral COVID-19 Antiviral From Merck
November 04, 2021
Tickers
MRK
From Benzinga
Is There Any Hope for Atea Pharmaceuticals Stock?
November 04, 2021
From Motley Fool
Moderna’s Outlook Is Directly Tied to the Eventual Receding of Covid-19
November 03, 2021
From InvestorPlace
7 Best Stocks to Buy Now If You Have Faith in These Analyst Upgrades
November 03, 2021
From InvestorPlace
Evpandpresident And Merck Animal Heallth Of Merck & Co Trades $11M In Company Stock
November 03, 2021
Tickers
MRK
From Benzinga
3 Explosive Biotech Stocks -- Could They Shoot Even Higher?
November 03, 2021
From Motley Fool
Here's How Much Extra Money Pfizer Will Make From Vaccines for Younger Kids This Year
November 02, 2021
From Motley Fool
ANI Pharma's Purified Cortrophin Gel Scores FDA Approval; Q3 Earnings Beat Estimates
November 01, 2021
From Benzinga
Merck Pushes Acceleron Buyout By Refiling For Antitrust Review
November 01, 2021
From Benzinga
Merck Dives Further Into Cytokine Research With Synthekine Deal
November 01, 2021
Tickers
MRK
From Benzinga
Pasithea and Evotec Team Up — Attempt to Make Headway on Brain Disorders
November 01, 2021
From Benzinga
2 Best Biotech Stocks to Buy in November
November 01, 2021
From Motley Fool
From Benzinga
Novavax Stock Is a Buy for Long-Term Investors on Its Pipeline Alone
November 01, 2021
From InvestorPlace
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
